|
1
|
Katsura C, Ogunmwonyi I, Kankam HK and
Saha S: Breast cancer: Presentation, investigation and management.
Br J Hosp Med (Lond). 83:1–7. 2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Criscitiello C and Corti C: Breast cancer
genetics: Diagnostics and treatment. Genes (Basel).
13(1593)2022.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wang R, Zhu Y, Liu X, Liao X, He J and Niu
L: The Clinicopathological features and survival outcomes of
patients with different metastatic sites in stage IV breast cancer.
BMC Cancer. 19(1091)2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Pérez-Montiel D, Serrano-Olvera A, Salazar
LC, Cetina-Pérez L, Candelaria M, Coronel J, Montalvo LA and de
León DC: Adenocarcinoma metastatic to the uterine cervix: A case
series. J Obstet Gynaecol Res. 38:541–549. 2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Mazur MT, Hsueh S and Gersell DJ:
Metastases to the female genital tract-Analysis of 325 case.
Cancer. 53:1978–1984. 1984.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Mathew A, Rajagopal PS, Villgran V, Sandhu
GS, Jankowitz RC, Jacob M, Rosenzweig M, Oesterreich S and Brufsky
A: Distinct pattern of metastases in patients with invasive lobular
carcinoma of the breast. Geburtsh Frauenheilk. 77:660–666.
2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Waks AG, Lennon J, Yadav BS, Hwang H,
dSchapirael Carmen M, Johnson NB, Reynolds K, Schapira L, Gilman PB
and Overmoyer B: Metastasis to the cervix uteri 15 years after
treatment of lobular carcinoma of the breast. Semin Oncol.
42:e81–e94. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Martinez V and Azzopardi JG: Invasive
lobular carcinoma of the breast: Incidence and variants.
Histopathology. 3:467–488. 1979.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Wang R, Zhu Y, Liu X, Liao X, He J and Niu
L: The clinicopathological features and survival outcomes of
patients with different metastatic sites in stage IV breast cancer.
BMC Cancer. 19(1091)2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Rahmani M, Nili F and Tabibian E:
Endometrial metastasis from ductal breast carcinoma: A case report
with literature review. Am J Case Rep. 19:494–499. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Lokadasan R, Ratheesan K, Sukumaran R and
Nair SP: Metastatic lobular carcinoma of breast mimics primary
cervix carcinoma: Two case reports and a review of the literature.
Ecancermedicalscience. 9(571)2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Enling L, Liqun W, Yanmei Z, et al:
Clinical study on endometrial lesions induced by tamoxifen in
postoperative breast cancer patients. Chin J Mod Med. 23:106–108.
2013.
|
|
14
|
Early Breast Cancer Trialists'
Collaborative Group (EBCTCG). Aromatase inhibitors versus tamoxifen
in early breast cancer: Patient-level meta-analysis of the
randomised trials. Lancet. 386:1341–1352. 2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ghanavati M, Khorshidi Y, Shadnoush M,
Akbari ME, Ardehali SH, Chavarri-Guerra Y, Akbari A,
Barragan-Carrillo R, Amlashi MA, Javid Z, et al: Tamoxifen use and
risk of endometrial cancer in breast cancer patients: A systematic
review and dose-response meta-analysis. Cancer Rep.
6(e1806)2023.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Committee Opinion No. 601. Tamoxifen and
uterine cancer. American College of Obstetricians and
Gynecologists. Obstet Gynecol. 123:1394–1397. 2014.
|
|
17
|
Singh P, Patro SS, Singhal T, Parida GK
and Agrawal K: Uterine metastasis presenting as abnormal uterine
bleeding in a case of primary breast cancer identified on
18F-FDG PET/CT. J Nucl Med Technol. 51:333–334.
2023.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Colak E, Erinanc OH and Ozdemir D:
Diagnosis of micropapillary carcinoma of the breast by endometrial
biopsy in a postmenopausal patient with abnormal uterine bleeding.
Ann Ital Chir. 10:2021.PubMed/NCBI
|
|
19
|
Arif SH, Mohammed AA and Mohammed FR:
Metastatic invasive lobular carcinoma of the breast to the
endometrium presenting with abnormal uterine bleeding; Case report.
Ann Med Surg (Lond). 51:41–43. 2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Ren M, Cai X, Jia L, Bai Q, Zhu X, Hu X,
Wang Q, Luo Z and Zhou X: Comprehensive analysis of cancer of
unknown primary and recommendation of a histological and
immunohisto-chemical diagnostic strategy from China. BMC Cancer.
23(1175)2023.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Asch-Kendrick R and Cimino-Mathews A: The
role of GATA3 in breast carcinomas: A review. Hum Pathol. 48:37–47.
2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Jingping Y, Juan W, Xinxin Y, et al: The
pathological diagnostic value of GATA3, MGB, and GCDFP-15 in breast
cancer. Chin J Endocr Surg. 14:94–99. 2020.
|
|
23
|
Rao M, Khade S, Chaudhary R, Singh P,
Yadav G, Elhence P, Nalwa A, Sharma R and Goel AD: Comparison of
GATA-3, mammaglobin and GCDFP-15 expression in primary, metastatic
and triple negative breast carcinomas: An Indian scenario. Asian
Pac J Cancer Prev. 24:509–515. 2023.PubMed/NCBI View Article : Google Scholar
|
|
24
|
O'Shaughnessy J: Extending survival with
chemotherapy in metastatic breast cancer. Oncologist. 10
(Suppl):S20–S29. 2005.PubMed/NCBI View Article : Google Scholar
|
